| Tumour evolution in hepatocellular carcinoma AJ Craig, J Von Felden, T Garcia-Lezana, S Sarcognato, A Villanueva Nature reviews Gastroenterology & hepatology 17 (3), 139-152, 2020 | 635 | 2020 |
| Cholangiocarcinoma S Sarcognato, D Sacchi, M Fassan, L Fabris, M Cadamuro, G Zanus, ... Pathologica 113 (3), 158, 2021 | 96 | 2021 |
| Obliterative portal venopathy without portal hypertension: an underestimated condition M Guido, S Sarcognato, A Sonzogni, MG Lucà, M Senzolo, S Fagiuoli, ... Liver International 36 (3), 454-460, 2016 | 84 | 2016 |
| Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis S Sarcognato, D Sacchi, F Grillo, N Cazzagon, L Fabris, M Cadamuro, ... Pathologica 113 (3), 170, 2021 | 75 | 2021 |
| Pathology of idiopathic non-cirrhotic portal hypertension M Guido, S Sarcognato, D Sacchi, G Colloredo Virchows Archiv 473, 23-31, 2018 | 68 | 2018 |
| Pathology of autoimmune hepatitis C Covelli, D Sacchi, S Sarcognato, N Cazzagon, F Grillo, F Baciorri, ... Pathologica 113 (3), 185, 2021 | 53 | 2021 |
| Hepatocellular carcinoma: a clinical and pathological overview SL Renne, S Sarcognato, D Sacchi, M Guido, M Roncalli, L Terracciano, ... Pathologica 113 (3), 203, 2021 | 46 | 2021 |
| Pathology of non-alcoholic fatty liver disease I Cataldo, S Sarcognato, D Sacchi, M Cacciatore, F Baciorri, A Mangia, ... Pathologica 113 (3), 194, 2021 | 30 | 2021 |
| Cholangiocyte senescence in primary sclerosing cholangitis is associated with disease severity and prognosis N Cazzagon, S Sarcognato, A Floreani, G Corrà, S De Martin, V Guzzardo, ... JHEP Reports 3 (3), 100286, 2021 | 29 | 2021 |
| Fucus vesiculosus and Ascophyllum nodosum Ameliorate Liver Function by Reducing Diet-Induced Steatosis in Rats D Gabbia, M Saponaro, S Sarcognato, M Guido, N Ferri, M Carrara, ... Marine Drugs 18 (1), 62, 2020 | 29 | 2020 |
| The extra virgin olive oil polyphenol oleocanthal exerts antifibrotic effects in the liver D Gabbia, S Carpi, S Sarcognato, L Cannella, M Colognesi, M Scaffidi, ... Frontiers in Nutrition 8, 715183, 2021 | 25 | 2021 |
| Sequential development of hepatocellular carcinoma and liver angiosarcoma in a vinyl chloride–exposed worker M Guido, S Sarcognato, G Pelletti, M Fassan, B Murer, R Snenghi Human pathology 57, 193-196, 2016 | 21 | 2016 |
| The diagnostic value of cytology in parotid Warthin's tumors: international multicenter series D Borsetto, JM Fussey, D Cazzador, J Smith, A Ciorba, S Pelucchi, ... Head & neck 42 (3), 522-529, 2020 | 20 | 2020 |
| Necroptosis in cholangiocarcinoma S Sarcognato, IEM de Jong, L Fabris, M Cadamuro, M Guido Cells 9 (4), 982, 2020 | 17 | 2020 |
| Mechanisms of action of drugs effective in hepatocellular carcinoma S Sarcognato, T García‐Lezana, A Villanueva Clinical Liver Disease 14 (2), 62-65, 2019 | 17 | 2019 |
| Prognostic role of BAP-1 and PBRM-1 expression in intrahepatic cholangiocarcinoma S Sarcognato, E Gringeri, M Fassan, M Di Giunta, V Maffeis, V Guzzardo, ... Virchows Archiv 474, 29-37, 2019 | 16 | 2019 |
| Focus on histological abnormalities of intrahepatic vasculature in chronic viral hepatitis M Guido, S Sarcognato, FP Russo, R Cardin, M Piciocchi, G Colloredo, ... Liver International 38 (10), 1770-1776, 2018 | 16 | 2018 |
| Metastasis to parotid gland from non Head and Neck tumors E Enzo, C Andrea, D Borsetto, D Cazzador, S Sarcognato, F Marino, ... JOURNAL OF BALKAN UNION OF ONCOLOGY 23, 163-166, 2018 | 16 | 2018 |
| Changes in micro RNA expression during disease progression in patients with chronic viral hepatitis A Sinigaglia, E Lavezzo, M Trevisan, T Sanavia, B Di Camillo, E Peta, ... Liver International 35 (4), 1324-1333, 2015 | 16 | 2015 |
| The phenolic compounds tyrosol and hydroxytyrosol counteract liver fibrogenesis via the transcriptional modulation of NADPH oxidases and oxidative stress-related miRNAs D Gabbia, S Carpi, S Sarcognato, I Zanotto, K Sayaf, M Colognesi, ... Biomedicine & Pharmacotherapy 157, 114014, 2023 | 14 | 2023 |
